Floatz logo

5-azacytidine

Childhood Solid Tumor

The Hospital for Sick ChildrenPhase 1Dormant
CC
47/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
95/ 100

Competitive context

33 Active assets in the Childhood Solid Tumor cohort.

Asset / SponsorPhaseRating
(+)-VINCRISTINE
Tianjin Medical University Cancer Institute and Hospital
Phase 2BB
Cyclophosphamide
St. Jude Children's Research Hospital
Phase 2BB
Nivolumab
Australian & New Zealand Children's Haematology/Oncology Group
Phase 2B
OTL-38
Mayo Clinic
Phase 3B
Irinotecan
Australian & New Zealand Children's Haematology/Oncology Group
Phase 1/2B

View all 50 →

Same molecule, other indications

5-azacytidine is also rated in:

Recurrent Non-Hodgkin LymphomaDormant
BB
Indicative ·
70 / 100
View asset →
Acute Myeloid Leukaemia; Myelodysplastic Syndromes;Chronic Myelomonocytic LeukemiaDormant
BB
Indicative ·
65 / 100
View asset →
myelodysplastic syndromeDormant
BB
Indicative ·
64 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →